ADB-HEXINACA

Legal status
Legal status	CA: Schedule II DE: NpSG (Industrial and scientific use only) UK: Class B US: Schedule I
Identifiers
IUPAC name N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-hexyl-1H-indazole-3-carboxamide
CAS Number	3047777-38-5 Y
PubChemCID	163191674
ChemSpider	109107958
CompTox Dashboard(EPA)	DTXSID701038279
Chemical and physical data
Formula	C20H30N4O2
Molar mass	358.486 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(N[C@@H](C(C)(C)C)C(N)=O)C1=NN(CCCCCC)C2=C1C=CC=C2
InChI InChI=1S/C20H30N4O2/c1-5-6-7-10-13-24-15-12-9-8-11-14(15)16(23-24)19(26)22-17(18(21)25)20(2,3)4/h8-9,11-12,17H,5-7,10,13H2,1-4H3,(H2,21,25)(H,22,26)/t17-/m1/s1 Key:PZMLDAGKYPJWHJ-QGZVFWFLSA-N

ADB-HEXINACA (also known asADB-HINACA andADMB-HEXINACA) is acannabinoiddesigner drug that has been found as an ingredient in somesynthetic cannabis products, first appearing in early 2021. It is a longer chainhomologue of previously encountered synthetic cannabinoid compounds such asADB-BUTINACA andADB-PINACA.^[1][2] The pharmacology of ADB-HEXINACA and numerous analogues at CB1 and CB2 receptors has been reported.^[3]

• 4F-ADB
• 5F-ADB-PINACA
• ADB-CHMINACA
• ADB-FUBINACA
• ADB-4en-PINACA
• JWH-019

• Cannabinoids
• Designer drugs
• Indazolecarboxamides
• Tert-butyl compounds

• Articles with short description
• Short description matches Wikidata
• Short description is different from Wikidata
• Articles without EBI source
• Chemical pages without DrugBank identifier
• Articles without KEGG source
• Articles without UNII source
• Drugs missing an ATC code
• Articles containing unverified chemical infoboxes